Vienna

Persia White set to Release Album "Love Letters" and new music video "ROBOT LOVE" on August 18th 2023

Retrieved on: 
Friday, August 18, 2023

NEW YORK, Aug. 17, 2023 /PRNewswire-PRWeb/ -- Acclaimed actress, musician, filmmaker, and activist Persia White is thrilled to announce her highly anticipated album, "Love Letters." The forthcoming album is an intimate collection of twelve songs each representing a love letter to her loved one. It will be released independently by her label Hybrid Music on August 18th, 2023 on iTunes, Band Camp, and PersiaWhiteMusic.com, available now on Band Camp and iTunes. "Love Letters" will also have a limited edition 12" LP pressed on BIO vinyl, making it one of the world's first plastic-free vinyl records ever produced, and will include a four-page LP booklet with pictures, lyrics and liner notes.

Key Points: 
  • The forthcoming album is an intimate collection of twelve songs each representing a love letter to her loved one.
  • It will be released independently by her label Hybrid Music on August 18th, 2023 on iTunes, Band Camp , and PersiaWhiteMusic.com, available now on Band Camp and iTunes.
  • Persia is well-known for her eight years on the award-winning TV series "Girlfriends" and "The Vampire Diaries."
  • The success of the single and video have garnered anticipation for the full album, as well as the dynamic new music video, "Robot Love," directed, produced, and edited by Persia White, out on August 18, 2023.

Press release - UN High Commissioner for Human Rights Volker Türk to address MEPs

Retrieved on: 
Wednesday, July 19, 2023

On Thursday, MEPs will welcome UN High Commissioner for Human Rights Volker Türk for a debate on the global state of human rights and fundamental freedoms.

Key Points: 
  • On Thursday, MEPs will welcome UN High Commissioner for Human Rights Volker Türk for a debate on the global state of human rights and fundamental freedoms.
  • Mr Türk’s visit to the European Parliament’s Subcommittee on Human Rights and the Civil Liberties Committee comes just after the 30th anniversary of the Vienna Declaration celebrated in June, a landmark document which established the office of the High Commissioner for Human Rights, and ahead of the 75th anniversary of the Universal Declaration of Human Rights in December.
  • The latter will also be the main focus of a European Parliament high-level conference in Brussels on 29 November 2023.
  • The speech by the High Commissioner, during his first visit to the European Parliament since his appointment in October 2022, also follows a recent visit by MEPs on the Subcommittee on Human Rights to Geneva, Switzerland, where they discussed the protection and promotion of human rights worldwide with UN officials and other stakeholders, including with Mr Türk.

Highlights - Exchange of views with Volker Türk, United Nations High Commissioner for Human Rights - Subcommittee on Human Rights

Retrieved on: 
Monday, July 17, 2023

Exchange of views with Volker Türk, United Nations High Commissioner for Human Rights

Key Points: 
  • Exchange of views with Volker Türk, United Nations High Commissioner for Human Rights
    17-07-2023 - 11:11
    The UN High Commissioner for Human Rights, Mr Volker Türk, will address for the first time Members of DROI and LIBE during a joint meeting organised on Thursday 20 July.
  • The meeting provides a timely opportunity to address human rights achievements and global challenges on the matter.
  • 2023 marks the 75th anniversary of the Universal Declaration of Human Rights and the 30th anniversary of the Vienna Declaration which established the Office of the High Commissioner for Human Rights (OHCHR).
  • The joint DROI and LIBE meeting with the UN High Commissioner for Human Rights will take place in Brussels (room 4Q1, Antall building) on Thursday, 20 July 2023, from 11.00-12.30.

China advocates safeguarding human rights through security, promoting human rights through development, promoting human rights through cooperation

Retrieved on: 
Saturday, June 17, 2023

Offering Chinese propositions in the letter, he stressed that China advocates safeguarding human rights with security, promoting human rights with development and advancing human rights with cooperation, which demonstrated China's sense of responsibility in participating in global human rights governance and promoting the progress of human rights development of the world.

Key Points: 
  • Offering Chinese propositions in the letter, he stressed that China advocates safeguarding human rights with security, promoting human rights with development and advancing human rights with cooperation, which demonstrated China's sense of responsibility in participating in global human rights governance and promoting the progress of human rights development of the world.
  • The politicization and instrumentalization of human rights is seriously poisoning the healthy development of the global human rights cause.
  • Only by adhering to solidarity and cooperation, communicating sincerely and profoundly on human rights issues and seeking consensus and managing disputes, can countries improve their human rights protection and promote the development of the global human rights cause.
  • The visions it has proposed, including promoting human rights with development, have won broad support and made important contributions to the development of the global human rights course.

EQS-News: Marinomed Biotech AG publishes clinical data on the effectiveness of its Carragelose nasal spray in the treatment of hay fever

Retrieved on: 
Saturday, April 15, 2023

Korneuburg, Austria, 12 April 2023 – Marinomed Biotech AG, listed on the Vienna Stock Exchange (VSE:MARI), today announced further positive results from its clinical study on the anti-allergic properties of its Carragelose nasal spray.

Key Points: 
  • Korneuburg, Austria, 12 April 2023 – Marinomed Biotech AG, listed on the Vienna Stock Exchange (VSE:MARI), today announced further positive results from its clinical study on the anti-allergic properties of its Carragelose nasal spray.
  • The open-label, cross-over, randomized clinical trial conducted at the Vienna Challenge Chamber showed that the nasal spray can significantly decrease the symptoms of allergic rhinitis (hay fever) in patients challenged with their respective allergen.
  • “Most recently, we have also published clinical data on the decongestant effect of the Sorbitol-containing Carragelose nasal spray.
  • To demonstrate prophylactic effectiveness, the treatment with the Carragelose nasal spray was applied before the allergic challenge.

EQS-News: Travelex Issuerco 2 Plc: Completion of £20 million funding raise

Retrieved on: 
Saturday, April 15, 2023

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • Following the announcement made by Travelex on 14 March 2023, Travelex is pleased to announce that it has successfully concluded the raising of £20 million of additional funding following the issuance of an additional number of new money notes (in a face value amount of approximately £20.7 million) by the Company (the "Additional New Money Notes") and the connected issuance of ordinary shares in Travelex Topco Limited, which are stapled to the Additional New Money Notes.
  • The Additional New Money Notes have the same terms and conditions and ISIN (XS2248458049) as the existing new money notes.
  • An application will shortly be made for the Additional New Money Notes to be admitted to trading on the Vienna MTF (as operated by the Vienna Stock Exchange) and an announcement will be made once such admission has occurred.

EQS-News: Travelex Issuerco 2 Plc: Admission of additional debt securities

Retrieved on: 
Saturday, April 15, 2023

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • Travelex is pleased to announce that the additional new money notes which were issued as part of the £20 million fundraising that concluded on 3 April 2023 (the “Additional New Money Notes”) were admitted to trading on the Vienna MTF (as operated by the Vienna Stock Exchange) on 5 April 2023.
  • The Additional New Money Notes have a face value amount of approximately £20.7 million.
  • The Additional New Money Notes have the same terms and conditions and ISIN (XS2248458049) as the existing new money notes.

OrbusNeich Announces First Annual Results After Listing, Record Revenue of US$136.8 Million, Adjusted Net Profit Up 25% to US$26.7 Million

Retrieved on: 
Wednesday, March 8, 2023

As a result, gross profit and adjusted net profit(1) both recorded an increase, by 13.9% to US$92.5 million and by 24.9% to US$26.7 million, respectively, while the gross margin remained at a healthy level of 67.6%.

Key Points: 
  • As a result, gross profit and adjusted net profit(1) both recorded an increase, by 13.9% to US$92.5 million and by 24.9% to US$26.7 million, respectively, while the gross margin remained at a healthy level of 67.6%.
  • The Group has further strengthened its financial position by raising approximately HK$480.8 million through its listing on HKEX.
  • Mr. David Chien, Chairman, Executive Director and Chief Executive Officer of OrbusNeich said, "The year 2022 marked an important milestone in OrbusNeich's history.
  • Ultimately, we achieved growth in both established and high-growth markets, as well as record-high revenue and a significant improvement in net profit."

EQS-News: Marinomed Biotech AG reports positive clinical data for the Carragelose decongestant nasal spray

Retrieved on: 
Thursday, March 16, 2023

Korneuburg, Austria, 14 March 2023 – Marinomed Biotech AG, listed on the Vienna Stock Exchange (VSE:MARI), today announced positive results from its clinical study on the decongestant effect of the Sorbitol-containing Carragelose nasal spray.

Key Points: 
  • Korneuburg, Austria, 14 March 2023 – Marinomed Biotech AG, listed on the Vienna Stock Exchange (VSE:MARI), today announced positive results from its clinical study on the decongestant effect of the Sorbitol-containing Carragelose nasal spray.
  • While Carragelose was shown to be an effective treatment of viral infections of the respiratory tract, Sorbitol exerts a decongestant effect.
  • The Carragelose and Sorbitol nasal spray was launched in 2018 and is currently marketed in 11 countries as a common cold product.
  • Based on the current clinical results, Marinomed plans to expand both the applications and target markets for the decongestant nasal spray.

Plant Phenotyping Market worth $437 million by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, January 12, 2023

The image analysis segment is expected to account for the largest share of the plant phenotyping market in 2022.

Key Points: 
  • The image analysis segment is expected to account for the largest share of the plant phenotyping market in 2022.
  • These are standalone or additional accessories that can be installed in plant phenotyping equipment systems.
  • The image analysis segment is expected to account for the largest share of the plant phenotyping market in 2022.
  • High emphasis on funding for plant phenotyping experiments from the government and other organizations in Europe and North America has played a vital role in the growth of the plant phenotyping market in these regions.